Letter to the EditorSuitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer
Abbreviations
COVID-19
The severe coronavirus disease 2019
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
CD24
Cluster of differentiation 24
ICB
Immune checkpoint blockade
TME
Tumor microenvironment
TIDE
Tumor immune dysfunction and exclusion
LGG
Brain Lower Grade Glioma
KIRC
Kidney renal clear cell carcinoma
BRCA
Breast invasive carcinoma
CESC
Cervical squamous cell carcinoma and endocervical adenocarcinoma
LIHC
Liver hepatocellular carcinoma
MESO
Mesothelioma
OS
Overall survival, PFS, Progression Free Survival
TCGA
The cancer genome atlas
GTEx
Genotype-Tissue Expression
KEGG
kyoto encyclopedia of genes and genomes
Cited by (0)
- 1
These authors contributed equally to this work.
© 2022 Published by Elsevier Ltd on behalf of The British Infection Association.